BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1296980)

  • 1. Methylprednisolone reduces the nephrotoxicity caused by cisplatin.
    Uozumi J; Koikawa Y; Ueda T
    J Pharmacobiodyn; 1992 Dec; 15(12):693-7. PubMed ID: 1296980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic effect of methylprednisolone against cisplatin-induced nephrotoxicity in rats.
    Koikawa Y; Uozumi J; Ueda T; Yasumasu T; Kumazawa J
    Toxicol Lett; 1993 Mar; 66(3):281-5. PubMed ID: 8475508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity in rats].
    Koikawa Y; Uozumi J; Yasumasu T; Ueda T; Kumazawa J
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1363-7. PubMed ID: 8346934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity].
    Koikawa Y
    Fukuoka Igaku Zasshi; 1995 Feb; 86(2):31-9. PubMed ID: 7729781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of methylprednisolone against cisplatin-induced nephrotoxicity in patients with urothelial tumors.
    Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Kumazawa J
    Int J Urol; 1996 Sep; 3(5):343-7. PubMed ID: 8886909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
    Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
    Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat.
    Goudie J; Chandra M; Lawrence GD; Williams P
    Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):33-49. PubMed ID: 8165368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of N-benzoyl amino acids on cisplatin nephrotoxicity in rats.
    Tokunaga J; Kobayashi M; Kitagawa A; Nakamura C; Arimori K; Nakano M
    Biol Pharm Bull; 1996 Nov; 19(11):1451-6. PubMed ID: 8951163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
    Mundhe NA; Kumar P; Ahmed S; Jamdade V; Mundhe S; Lahkar M
    Int Immunopharmacol; 2015 Sep; 28(1):634-42. PubMed ID: 26247680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative nephrotoxicity of tetraplatin and cisplatin in rats.
    Rahman A; Roh JK; Preuss HG
    Nephron; 1993; 64(2):289-95. PubMed ID: 8321364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methylprednisolone on cisplatin-induced nephrotoxicity in rat renal cortical slices.
    Uozumi J; Koikawa Y; Yasumasu T; Ueda T; Kumazawa J
    Res Exp Med (Berl); 1995; 195(4):231-5. PubMed ID: 8525073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
    Zhang JS; Imai T; Otagiri M
    Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
    Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth inhibition of LLC-PK1 cells by cisplatin in vitro.
    Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Ueda T; Kumazawa J
    Res Exp Med (Berl); 1996; 196(4):211-7. PubMed ID: 8903096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of cisplatin nephrotoxicity with glycine: dose dependency in rats.
    Li Q; Bowmer CJ; Yates MS
    J Pharm Pharmacol; 1995 Mar; 47(3):223-6. PubMed ID: 7602485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dosing time and schedule on cisplatin-induced nephrotoxicity in rats.
    Kobayashi M; To H; Yuzawa M; Hakamata Y; Higuchi S; Tokue A; Fujimura A; Kobayashi E
    J Pharm Pharmacol; 2000 Oct; 52(10):1233-7. PubMed ID: 11092567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and quantitative detection of cisplatin-induced nephrotoxicity by measurement of plasma PSP (phenolsulfonphthalein) half-life in rats.
    Uozumi J; Ueda T; Koikawa Y; Yasumasu T; Kumazawa J
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):901-4. PubMed ID: 8254999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK1 cells and rats.
    Kim YH; Kim YW; Oh YJ; Back NI; Chung SA; Chung HG; Jeong TS; Choi MS; Lee KT
    Biol Pharm Bull; 2006 Dec; 29(12):2436-41. PubMed ID: 17142978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of safranal to cisplatin-induced nephrotoxicity.
    Karafakıoğlu YS; Bozkurt MF; Hazman Ö; Fıdan AF
    Biochem J; 2017 Mar; 474(7):1195-1203. PubMed ID: 28188255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity.
    Sahin K; Orhan C; Tuzcu M; Muqbil I; Sahin N; Gencoglu H; Guler O; Padhye SB; Sarkar FH; Mohammad RM
    Biol Trace Elem Res; 2014 Feb; 157(2):156-63. PubMed ID: 24415068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.